As we prepare for the festive season, it’s easy to let COVID boosters fall off our to-do lists. But COVID is still ...

ACIP has drifted toward inflating speculative risks while downplaying well-established vaccine benefits,” write former CDC officials Demetre Daskalakis, Daniel Jernigan, and Debra Houry.

Vaccine effectiveness also dropped from 75.2% to 39.7% among immunocompromised individuals. Authors note that the RSV vaccine is still effective, but older and immunocompromised individuals may ...

Australia has a new Covid-19 vaccine aimed at tackling the latest, fast-spreading variant. The Pfizer-BioNTech mRNA vaccine ...